ABBV-744 CLINICAL TRIAL PHASE 2 DATA THINGS TO KNOW BEFORE YOU BUY

In Segment A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to recognize Protected dosing program. Further participants will probably be enrolled at the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be provided as "add-on" therapy. In Section C, participants